AdvaMed Praises New Version of Disclosure Bill

AdvaMed said it supports the changes recently made to a Senate bill on disclosure to patients of doctors' financial ties to drug and device companies. "This bill is an important step forward in improving transparency and does so in a manner that does not jeopardize future innovation. That’s good news for patients, physicians and industry," said Stephen J.

May 22, 2008

1 Min Read
AdvaMed Praises New Version of Disclosure Bill

Ubl, president and CEO of AdvaMed.The modifications include preemption of state disclosure laws to ensure consistency; requiring compliance by physician-owned manufacturers, distributors, and group purchasing organizations; and requiring disclosure information to be displayed in an easy-to-understand manner. AdvaMed would like to see one more change: exempting companies who pay less than $250,000 per year to physicians.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like